These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26390952)

  • 21. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
    Beral V; Banks E; Reeves G
    Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The menopause, hormone replacement therapy and breast cancer.
    Marsden J
    J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):123-32. PubMed ID: 12650709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies.
    Fernandez E; Gallus S; Bosetti C; Franceschi S; Negri E; La Vecchia C
    Int J Cancer; 2003 Jun; 105(3):408-12. PubMed ID: 12704678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elements of informed consent for hormone replacement therapy in patients with diagnosed breast cancer.
    Chlebowski RT; McTiernan A
    J Clin Oncol; 1999 Jan; 17(1):130-42. PubMed ID: 10458226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European Code against Cancer 4th Edition: Ultraviolet radiation and cancer.
    Greinert R; de Vries E; Erdmann F; Espina C; Auvinen A; Kesminiene A; Schüz J
    Cancer Epidemiol; 2015 Dec; 39 Suppl 1():S75-83. PubMed ID: 26096748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issue.
    Ruan X; Mueck AO
    Horm Mol Biol Clin Investig; 2018 Aug; 37(1):. PubMed ID: 30120909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Menopause, hormone replacement therapy and cancer.
    La Vecchia C; Brinton LA; McTiernan A
    Maturitas; 2001 Aug; 39(2):97-115. PubMed ID: 11514109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies.
    Negri E; Tzonou A; Beral V; Lagiou P; Trichopoulos D; Parazzini F; Franceschi S; Booth M; La Vecchia C
    Int J Cancer; 1999 Mar; 80(6):848-51. PubMed ID: 10074916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disturbances of endometrial bleeding with hormone replacement therapy.
    Thomas AM; Hickey M; Fraser IS
    Hum Reprod; 2000 Aug; 15 Suppl 3():7-17. PubMed ID: 11041216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study.
    Close H; Mason JM; Wilson D; Hungin AP
    BMC Gastroenterol; 2012 May; 12():56. PubMed ID: 22642788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study.
    Ewertz M; Mellemkjaer L; Poulsen AH; Friis S; Sørensen HT; Pedersen L; McLaughlin JK; Olsen JH
    Br J Cancer; 2005 Apr; 92(7):1293-7. PubMed ID: 15785751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in Spain.
    Chilet-Rosell E; Martín Llaguno M; Ruiz Cantero MT; Alonso-Coello P
    BMC Public Health; 2010 Mar; 10():134. PubMed ID: 20233393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Benefit-risk balance of hormone replacement therapy: Cancers and mortality. Postmenopausal women management - CNGOF and GEMVi clinical practice guidelines].
    Poudou C; Baffet H; Nadeau C; Rolland AL; Catteau-Jonard S; Robin G
    Gynecol Obstet Fertil Senol; 2021 May; 49(5):462-473. PubMed ID: 33771739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exogenous steroids for menopausal symptoms and breast/endometrial cancer risk.
    Mourits MJ; DE Bock GH
    Int J Gynecol Cancer; 2006; 16 Suppl 2():494-6. PubMed ID: 17010054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European Code against Cancer 4th Edition: Breastfeeding and cancer.
    Scoccianti C; Key TJ; Anderson AS; Armaroli P; Berrino F; Cecchini M; Boutron-Ruault MC; Leitzmann M; Norat T; Powers H; Schüz J; Wiseman M; Romieu I
    Cancer Epidemiol; 2015 Dec; 39 Suppl 1():S101-6. PubMed ID: 26116994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hormonal replacement therapy and breast cancer].
    This P
    Rev Prat; 2005 Feb; 55(4):377-82. PubMed ID: 15828615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European Code against Cancer 4th Edition: Environment, occupation and cancer.
    Espina C; Straif K; Friis S; Kogevinas M; Saracci R; Vainio H; Schüz J
    Cancer Epidemiol; 2015 Dec; 39 Suppl 1():S84-92. PubMed ID: 26164655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.